Literature DB >> 25389612

Acute positive titers of antibody to coxsackievirus in acute idiopathic maculopathy.

Catherine B Meyerle1, Lawrence A Yannuzzi.   

Abstract

PURPOSE: To describe a case of acute idiopathic maculopathy (AIM) with positive antibody titers indicative of acute infection with coxsackievirus, the suspected etiology of this disorder.
METHODS: A 15-year-old boy presented with acute severe central visual loss in the left eye after a sore throat with pustular lesions. Visual acuity was 20/200, and fundus examination revealed a pigmented plaque at the level of the retinal pigment epithelium with an overlying neurosensory detachment.
RESULTS: Titers of antibody to coxsackievirus, measured by complement fixation testing, were positive for acute infection with coxsackievirus B1. Our treatment recommendation was observation. In a few weeks, visual acuity spontaneously returned to 20/20 as the exudative changes resolved leaving only a bull's eye-type lesion.
CONCLUSION: Determination of titers of antibody to coxsackievirus, as shown by our case, is a useful laboratory test along with careful fundus biomicroscopy and history taking to confirm a clinical suspicion for AIM.

Entities:  

Year:  2008        PMID: 25389612     DOI: 10.1097/01.iae.0000243065.91330.e0

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  3 in total

1.  Long-term multimodal imaging in acute posterior multifocal placoid pigment epitheliopathy and association with coxsackievirus exposure.

Authors:  Alexa L Li; Neal V Palejwala; Jessica G Shantha; Ghazala O'Keefe; Cecilia S Lee; Thomas Albini; Steven Yeh
Journal:  PLoS One       Date:  2020-08-24       Impact factor: 3.752

2.  Pseudomembranous conjunctivitis with hand, foot and mouth disease in a pregnant woman : a case report.

Authors:  Yoo Jin Kim; Tae Gi Kim
Journal:  BMC Ophthalmol       Date:  2021-03-02       Impact factor: 2.209

3.  Bilateral idiopathic retinal vasculitis following coxsackievirus A4 infection: a case report.

Authors:  Izumi Mine; Manzo Taguchi; Yutaka Sakurai; Masaru Takeuchi
Journal:  BMC Ophthalmol       Date:  2017-07-19       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.